InvestorsHub Logo
Followers 737
Posts 75947
Boards Moderated 0
Alias Born 01/01/2012

Re: Dyno89 post# 197990

Tuesday, 05/07/2024 6:43:43 PM

Tuesday, May 07, 2024 6:43:43 PM

Post# of 198625
There isn't a Clone 3 patent - the insiders control the vote - retail shareholders have to sit and watch their investment disappear.

Do you guys ever do any research?

"Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)

InventorJoseph P. Cotropia
Current Assignee BIO CLONETICS BIOCLONETICS IMMUNOTHERAPEUTICS Inc

Application US07/633,964 events
1990-12-26
Application filed by Bioclonetics Inc
1990-12-26
Priority to US07/633,964
1995-10-17
Publication of US5459060A
1995-10-17
Application granted
Anticipated expiration 2012-10-17
Status. Expired - Lifetime"

"Abstract
Disclosed is a human monoclonal antibody produced by the hybridoma designated Clone 3 and having A.T.C.C. Accession No. CRL 10198."

The Clone 3 patent didn't have any commercial value.

Then we have:

"A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates
J Cotropia et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul.

Abstract
A potential component that may be useful for passive immunotherapy for HIV-1 is human monoclonal antibodies (HumAbs) possessing potent anti-HIV-1 activity that is directed against conserved regions of the envelope glycoprotein. Such antibodies would, in principle, have the ability to neutralize diverse isolates of HIV-1...

Therefore, clone 3 reactivity defines a conserved neutralizable site on the HIV-1 transmembrane glycoprotein. Clone 3 and the conserved immunogenic epitope on gp41 could be useful in passive and active immunotherapy for the acquired immunodeficiency syndrome (AIDS)."

Clone 3 has been pumped since at least 1990.

ENZC has nothing of value.

IG

The First Casualty of Emotion is Reason.